Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp2
|
ENSMUSG00000029563.10 | forkhead box P2 |
Foxp3
|
ENSMUSG00000039521.6 | forkhead box P3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_14900080_14900231 | Foxp2 | 1194 | 0.651481 | 0.77 | 4.1e-12 | Click! |
chr6_14898190_14898764 | Foxp2 | 2872 | 0.412424 | 0.77 | 6.8e-12 | Click! |
chr6_14899811_14900028 | Foxp2 | 1430 | 0.591135 | 0.77 | 8.0e-12 | Click! |
chr6_15184573_15184755 | Foxp2 | 17 | 0.989409 | 0.75 | 4.1e-11 | Click! |
chr6_15197312_15197534 | Foxp2 | 459 | 0.905022 | 0.74 | 1.4e-10 | Click! |
chrX_7573528_7573933 | Foxp3 | 86 | 0.516565 | 0.46 | 4.1e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_54921010_54921324 | 58.10 |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
1042 |
0.54 |
chr2_53105833_53106109 | 57.87 |
Prpf40a |
pre-mRNA processing factor 40A |
39338 |
0.2 |
chr10_126641848_126642305 | 53.88 |
Gm40797 |
predicted gene, 40797 |
21922 |
0.18 |
chr16_17987771_17988057 | 44.28 |
Vpreb2 |
pre-B lymphocyte gene 2 |
7486 |
0.13 |
chr10_93234438_93234589 | 44.23 |
Cdk17 |
cyclin-dependent kinase 17 |
4510 |
0.24 |
chr2_28882454_28882605 | 40.39 |
Ddx31 |
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31 |
25388 |
0.13 |
chr8_25911581_25911764 | 40.15 |
Kcnu1 |
potassium channel, subfamily U, member 1 |
8 |
0.97 |
chr2_181766899_181767258 | 40.10 |
Myt1 |
myelin transcription factor 1 |
36 |
0.97 |
chr17_66444006_66444362 | 37.57 |
Mtcl1 |
microtubule crosslinking factor 1 |
4185 |
0.18 |
chr17_72194935_72195301 | 37.22 |
Gm19183 |
predicted gene, 19183 |
61140 |
0.15 |
chr3_76654290_76654629 | 34.54 |
Fstl5 |
follistatin-like 5 |
60909 |
0.15 |
chr7_6435396_6435733 | 33.09 |
Olfr1344 |
olfactory receptor 1344 |
3124 |
0.1 |
chr12_29789878_29790063 | 32.62 |
Myt1l |
myelin transcription factor 1-like |
50240 |
0.17 |
chr13_90885930_90886406 | 32.34 |
Atp6ap1l |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
12656 |
0.19 |
chr1_133265100_133265672 | 31.51 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
4070 |
0.17 |
chr13_83988136_83988456 | 31.04 |
Gm4241 |
predicted gene 4241 |
305 |
0.91 |
chr12_9901890_9902353 | 30.98 |
Gm22845 |
predicted gene, 22845 |
36671 |
0.21 |
chr6_147061739_147061930 | 30.11 |
Mrps35 |
mitochondrial ribosomal protein S35 |
583 |
0.66 |
chr2_174074570_174075340 | 30.10 |
Stx16 |
syntaxin 16 |
1353 |
0.41 |
chr13_90973481_90973651 | 29.97 |
Rps23 |
ribosomal protein S23 |
49381 |
0.15 |
chr14_122324157_122324364 | 28.42 |
Gm25464 |
predicted gene, 25464 |
63900 |
0.09 |
chr13_84449354_84449551 | 28.41 |
Gm26927 |
predicted gene, 26927 |
109339 |
0.06 |
chr2_113534586_113534746 | 28.34 |
Gm13964 |
predicted gene 13964 |
30632 |
0.17 |
chr1_81594178_81594459 | 28.31 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr15_83998114_83998513 | 28.16 |
Efcab6 |
EF-hand calcium binding domain 6 |
9331 |
0.2 |
chr4_149568802_149568983 | 28.05 |
Gm13066 |
predicted gene 13066 |
1102 |
0.37 |
chr4_151107641_151107996 | 27.78 |
Camta1 |
calmodulin binding transcription activator 1 |
485 |
0.8 |
chr4_82532408_82532766 | 27.77 |
Gm11266 |
predicted gene 11266 |
24571 |
0.17 |
chr3_137529694_137529872 | 27.48 |
Gm4861 |
predicted gene 4861 |
22839 |
0.2 |
chr7_96596444_96596765 | 27.44 |
Gm15414 |
predicted gene 15414 |
32465 |
0.19 |
chr18_25678184_25678915 | 27.41 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr6_58895029_58895188 | 27.14 |
Herc3 |
hect domain and RLD 3 |
5013 |
0.2 |
chr16_77788297_77788506 | 26.53 |
Gm17333 |
predicted gene, 17333 |
58203 |
0.11 |
chr8_120257070_120257224 | 26.46 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
28691 |
0.15 |
chr13_26283619_26284108 | 26.09 |
1700092E19Rik |
RIKEN cDNA 1700092E19 gene |
28484 |
0.22 |
chr6_92755852_92756003 | 26.06 |
Prickle2 |
prickle planar cell polarity protein 2 |
49772 |
0.14 |
chr10_39535386_39535619 | 26.03 |
Fyn |
Fyn proto-oncogene |
2232 |
0.3 |
chr6_103944408_103944702 | 26.02 |
Gm21054 |
predicted gene, 21054 |
20084 |
0.27 |
chr7_79525641_79525821 | 25.89 |
Mir9-3hg |
Mir9-3 host gene |
2119 |
0.16 |
chr2_136713076_136713349 | 25.87 |
Snap25 |
synaptosomal-associated protein 25 |
241 |
0.93 |
chr2_56539846_56540169 | 25.79 |
Mir195b |
microRNA 195b |
245804 |
0.02 |
chr4_95278363_95278679 | 25.70 |
Gm12708 |
predicted gene 12708 |
85159 |
0.08 |
chr12_48222098_48222420 | 25.33 |
Gm46327 |
predicted gene, 46327 |
174725 |
0.03 |
chr6_58932915_58933165 | 25.30 |
Herc3 |
hect domain and RLD 3 |
25778 |
0.12 |
chr9_101250559_101250710 | 25.24 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
1161 |
0.42 |
chr12_29789065_29789261 | 25.24 |
Myt1l |
myelin transcription factor 1-like |
51047 |
0.17 |
chr1_154816965_154817147 | 25.20 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
115 |
0.98 |
chr14_29029040_29029191 | 25.12 |
Lrtm1 |
leucine-rich repeats and transmembrane domains 1 |
8243 |
0.2 |
chr8_65617940_65618821 | 25.08 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr6_86487222_86488124 | 25.05 |
2310040G24Rik |
RIKEN cDNA 2310040G24 gene |
531 |
0.56 |
chr9_83316530_83316798 | 25.02 |
Gm46123 |
predicted gene, 46123 |
29495 |
0.16 |
chr14_64589182_64589588 | 24.98 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
310 |
0.8 |
chr15_44836338_44836578 | 24.95 |
A930017M01Rik |
RIKEN cDNA A930017M01 gene |
44961 |
0.14 |
chr13_84571624_84571828 | 24.92 |
Gm26913 |
predicted gene, 26913 |
119215 |
0.06 |
chr1_42693315_42693672 | 24.43 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
340 |
0.76 |
chr11_75796610_75796761 | 24.39 |
Doc2b |
double C2, beta |
636 |
0.6 |
chr13_83740093_83740300 | 24.30 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1333 |
0.24 |
chr4_53315308_53316054 | 24.24 |
Gm12495 |
predicted gene 12495 |
7455 |
0.21 |
chr2_122708149_122708787 | 24.20 |
4930417H01Rik |
RIKEN cDNA 4930417H01 gene |
425 |
0.78 |
chr4_21932308_21932628 | 24.16 |
Faxc |
failed axon connections homolog |
1111 |
0.54 |
chr4_114818962_114819553 | 24.01 |
Gm12830 |
predicted gene 12830 |
2465 |
0.28 |
chr3_34521806_34521966 | 23.85 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
38442 |
0.12 |
chr19_45920616_45920960 | 23.77 |
Armh3 |
armadillo-like helical domain containing 3 |
15641 |
0.16 |
chr3_17619540_17619872 | 23.76 |
Gm38154 |
predicted gene, 38154 |
50982 |
0.17 |
chr5_46151879_46152236 | 23.66 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
219648 |
0.02 |
chr8_9158822_9158973 | 23.62 |
Gm44516 |
predicted gene 44516 |
1676 |
0.31 |
chr8_12486572_12486996 | 23.58 |
4933439N14Rik |
RIKEN cDNA 4933439N14 gene |
16115 |
0.15 |
chr2_3420278_3420597 | 23.56 |
Meig1 |
meiosis expressed gene 1 |
1308 |
0.32 |
chr17_56551768_56552114 | 23.31 |
Gm20219 |
predicted gene, 20219 |
2446 |
0.18 |
chr6_25686769_25687229 | 23.29 |
Gpr37 |
G protein-coupled receptor 37 |
2793 |
0.38 |
chr2_159393037_159393200 | 23.23 |
Gm14219 |
predicted gene 14219 |
63339 |
0.15 |
chr2_94479768_94480087 | 23.16 |
Api5 |
apoptosis inhibitor 5 |
41791 |
0.13 |
chr9_107698465_107699106 | 23.16 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
6071 |
0.1 |
chr10_100127919_100128115 | 23.15 |
Gm22918 |
predicted gene, 22918 |
11484 |
0.14 |
chr8_70120126_70120277 | 23.06 |
Ncan |
neurocan |
672 |
0.45 |
chr4_22835787_22836371 | 22.98 |
Gm24078 |
predicted gene, 24078 |
88948 |
0.09 |
chr11_25156710_25156955 | 22.74 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
75794 |
0.11 |
chr2_168601687_168602100 | 22.70 |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
236 |
0.94 |
chr13_48130669_48130883 | 22.59 |
Gm36101 |
predicted gene, 36101 |
99003 |
0.06 |
chr4_5962411_5962640 | 22.57 |
Gm11796 |
predicted gene 11796 |
107038 |
0.07 |
chr16_44538220_44538681 | 22.41 |
Mir3081 |
microRNA 3081 |
19679 |
0.18 |
chr11_50887848_50888049 | 22.40 |
Zfp454 |
zinc finger protein 454 |
297 |
0.81 |
chrX_13346707_13347908 | 22.39 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr5_133107048_133107402 | 22.26 |
Gm38373 |
predicted gene, 38373 |
311072 |
0.01 |
chr15_37135024_37136161 | 22.21 |
Gm9509 |
predicted gene 9509 |
36812 |
0.14 |
chr3_50678326_50678497 | 22.15 |
Gm37461 |
predicted gene, 37461 |
4990 |
0.24 |
chr6_94631038_94631254 | 22.10 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
24379 |
0.17 |
chr14_66378030_66378639 | 22.10 |
Stmn4 |
stathmin-like 4 |
33953 |
0.15 |
chr1_131351910_131352118 | 22.08 |
Srgap2 |
SLIT-ROBO Rho GTPase activating protein 2 |
7467 |
0.14 |
chr1_6800590_6800877 | 22.07 |
St18 |
suppression of tumorigenicity 18 |
2058 |
0.39 |
chr1_180042028_180042179 | 22.02 |
Gm38169 |
predicted gene, 38169 |
21041 |
0.19 |
chr17_42939581_42939839 | 22.01 |
Cd2ap |
CD2-associated protein |
63045 |
0.13 |
chr18_4838430_4838581 | 21.88 |
Gm10556 |
predicted gene 10556 |
26019 |
0.22 |
chr15_25291827_25292014 | 21.85 |
4930445E18Rik |
RIKEN cDNA 4930445E18 gene |
40728 |
0.13 |
chr13_84056571_84056869 | 21.82 |
Gm17750 |
predicted gene, 17750 |
8052 |
0.22 |
chr9_83664968_83665283 | 21.79 |
Gm36120 |
predicted gene, 36120 |
22400 |
0.17 |
chr8_64319023_64319174 | 21.73 |
Gm35521 |
predicted gene, 35521 |
98002 |
0.07 |
chr3_42892130_42892312 | 21.72 |
Gm38044 |
predicted gene, 38044 |
306622 |
0.01 |
chr5_112521223_112521397 | 21.72 |
Sez6l |
seizure related 6 homolog like |
46183 |
0.1 |
chr7_73374751_73375071 | 21.68 |
Rgma |
repulsive guidance molecule family member A |
598 |
0.51 |
chr15_8659416_8659937 | 21.66 |
Gm37310 |
predicted gene, 37310 |
4603 |
0.23 |
chr1_190334220_190334375 | 21.61 |
Gm29678 |
predicted gene, 29678 |
69348 |
0.11 |
chr1_82766615_82767003 | 21.61 |
Tm4sf20 |
transmembrane 4 L six family member 20 |
1652 |
0.2 |
chr12_29240002_29240213 | 21.59 |
Gm6989 |
predicted gene 6989 |
77461 |
0.1 |
chr1_154500574_154500773 | 21.55 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
23977 |
0.25 |
chr5_131532078_131532239 | 21.48 |
Auts2 |
autism susceptibility candidate 2 |
2239 |
0.3 |
chr5_63648312_63648463 | 21.47 |
Nwd2 |
NACHT and WD repeat domain containing 2 |
715 |
0.65 |
chr2_10737244_10737438 | 21.46 |
Gm18547 |
predicted gene, 18547 |
156368 |
0.01 |
chr13_84783122_84783632 | 21.45 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chr9_56738591_56739084 | 21.41 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
30286 |
0.16 |
chr4_94978559_94979517 | 21.34 |
Mysm1 |
myb-like, SWIRM and MPN domains 1 |
4 |
0.67 |
chr4_72384628_72385513 | 21.28 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr1_32463374_32463525 | 21.24 |
Gm37999 |
predicted gene, 37999 |
10308 |
0.17 |
chr6_8956269_8957017 | 21.20 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr3_51531887_51532536 | 21.20 |
Setd7 |
SET domain containing (lysine methyltransferase) 7 |
4436 |
0.12 |
chr1_42691558_42691883 | 21.15 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
1373 |
0.31 |
chr4_151139945_151140096 | 21.15 |
Camta1 |
calmodulin binding transcription activator 1 |
436 |
0.86 |
chr5_133718570_133718754 | 21.14 |
Gm36667 |
predicted gene, 36667 |
120256 |
0.06 |
chr13_71507941_71508418 | 21.07 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20572 |
0.26 |
chr1_25179698_25179849 | 21.07 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
24950 |
0.16 |
chr1_168598218_168598422 | 21.05 |
1700063I16Rik |
RIKEN cDNA 1700063I16 gene |
77562 |
0.11 |
chr13_84751407_84751558 | 20.95 |
Gm26913 |
predicted gene, 26913 |
60541 |
0.15 |
chr2_49815790_49816032 | 20.83 |
Gm13480 |
predicted gene 13480 |
2963 |
0.3 |
chr10_11515311_11515489 | 20.62 |
Gm48679 |
predicted gene, 48679 |
10104 |
0.23 |
chr7_62046082_62046717 | 20.57 |
Mir344f |
microRNA Mir344f |
151 |
0.94 |
chr11_17750354_17750848 | 20.57 |
Gm12016 |
predicted gene 12016 |
111418 |
0.07 |
chrX_101222893_101223079 | 20.47 |
Snx12 |
sorting nexin 12 |
423 |
0.73 |
chr3_68573242_68573402 | 20.43 |
Schip1 |
schwannomin interacting protein 1 |
1077 |
0.57 |
chr18_42161644_42161798 | 20.43 |
Cstdc7 |
cystatin domain containing 7 |
11649 |
0.13 |
chr3_26835054_26835226 | 20.43 |
Gm37659 |
predicted gene, 37659 |
177624 |
0.03 |
chr4_59552972_59553132 | 20.42 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
3688 |
0.18 |
chr13_84055045_84055217 | 20.41 |
Gm17750 |
predicted gene, 17750 |
9641 |
0.21 |
chr1_66388570_66388940 | 20.37 |
Map2 |
microtubule-associated protein 2 |
1744 |
0.39 |
chr3_34649198_34650117 | 20.37 |
Sox2 |
SRY (sex determining region Y)-box 2 |
748 |
0.5 |
chr1_6733683_6734408 | 20.36 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chr13_31632507_31632686 | 20.35 |
Gm27516 |
predicted gene, 27516 |
6053 |
0.14 |
chr18_80984653_80984858 | 20.31 |
Sall3 |
spalt like transcription factor 3 |
1781 |
0.25 |
chr3_127408245_127408547 | 20.28 |
Ank2 |
ankyrin 2, brain |
558 |
0.7 |
chr6_116894386_116894537 | 20.26 |
Gm43926 |
predicted gene, 43926 |
59058 |
0.12 |
chr11_113788543_113789130 | 20.21 |
Sdk2 |
sidekick cell adhesion molecule 2 |
21587 |
0.15 |
chr4_48771189_48771406 | 20.14 |
Gm24573 |
predicted gene, 24573 |
8335 |
0.21 |
chr10_21882446_21882655 | 20.10 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
181 |
0.94 |
chr7_129937635_129938453 | 20.01 |
Gm4265 |
predicted gene 4265 |
24121 |
0.24 |
chr12_13984416_13984607 | 20.01 |
Gm48479 |
predicted gene, 48479 |
28573 |
0.19 |
chr18_64889548_64889699 | 20.00 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
594 |
0.63 |
chr10_49783011_49783191 | 19.98 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
158 |
0.95 |
chr16_63658694_63658869 | 19.93 |
Gm22769 |
predicted gene, 22769 |
88753 |
0.1 |
chr12_79782713_79783051 | 19.90 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
141851 |
0.04 |
chr14_11683845_11684071 | 19.88 |
Gm48602 |
predicted gene, 48602 |
83985 |
0.09 |
chr1_78167977_78168321 | 19.87 |
Pax3 |
paired box 3 |
28689 |
0.2 |
chr12_80061788_80062584 | 19.87 |
Gm36660 |
predicted gene, 36660 |
19248 |
0.14 |
chr8_5472683_5472841 | 19.83 |
Gm44693 |
predicted gene 44693 |
31772 |
0.2 |
chrX_10479451_10479602 | 19.80 |
Tspan7 |
tetraspanin 7 |
5632 |
0.24 |
chr7_30785794_30786000 | 19.75 |
Krtdap |
keratinocyte differentiation associated protein |
1999 |
0.15 |
chr3_51096175_51096378 | 19.72 |
Gm38246 |
predicted gene, 38246 |
7384 |
0.2 |
chr10_4106130_4106437 | 19.71 |
Gm25515 |
predicted gene, 25515 |
1970 |
0.37 |
chr6_141434067_141434222 | 19.67 |
Gm43958 |
predicted gene, 43958 |
8216 |
0.27 |
chr15_66731172_66731522 | 19.67 |
Tg |
thyroglobulin |
4903 |
0.23 |
chr1_59602905_59603078 | 19.60 |
Gm973 |
predicted gene 973 |
3791 |
0.17 |
chr3_17797861_17798083 | 19.60 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
2228 |
0.25 |
chr9_83405257_83405408 | 19.60 |
Lca5 |
Leber congenital amaurosis 5 (human) |
3463 |
0.18 |
chr14_13198578_13198745 | 19.60 |
Gm5087 |
predicted gene 5087 |
27759 |
0.23 |
chr8_36457363_36458468 | 19.57 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr13_96175937_96176114 | 19.56 |
Gm29543 |
predicted gene 29543 |
42656 |
0.13 |
chr14_124195911_124196083 | 19.54 |
Fgf14 |
fibroblast growth factor 14 |
3095 |
0.38 |
chr14_18572950_18573212 | 19.53 |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
24160 |
0.17 |
chr2_102072971_102073122 | 19.51 |
Gm13920 |
predicted gene 13920 |
15459 |
0.2 |
chr4_55015608_55015759 | 19.48 |
Zfp462 |
zinc finger protein 462 |
4203 |
0.3 |
chr18_38379687_38380169 | 19.47 |
Gm4949 |
predicted gene 4949 |
19390 |
0.11 |
chr8_114109511_114109662 | 19.44 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
23971 |
0.25 |
chr13_52457883_52458068 | 19.44 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr3_129532032_129532296 | 19.41 |
Gm35986 |
predicted gene, 35986 |
55 |
0.68 |
chr13_110280472_110281172 | 19.40 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr13_28416864_28417183 | 19.39 |
Gm40841 |
predicted gene, 40841 |
2840 |
0.33 |
chr2_62339289_62339443 | 19.36 |
Dpp4 |
dipeptidylpeptidase 4 |
5780 |
0.2 |
chr6_49021180_49021442 | 19.35 |
Gpnmb |
glycoprotein (transmembrane) nmb |
15235 |
0.08 |
chr16_20619519_20619670 | 19.28 |
Camk2n2 |
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
1693 |
0.13 |
chr18_84232190_84232510 | 19.28 |
Gm50311 |
predicted gene, 50311 |
29426 |
0.2 |
chr14_12559317_12559491 | 19.26 |
Cadps |
Ca2+-dependent secretion activator |
13003 |
0.23 |
chr3_55873315_55873490 | 19.26 |
Gm43376 |
predicted gene 43376 |
16904 |
0.19 |
chr10_92163346_92163542 | 19.26 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
304 |
0.91 |
chr12_44338422_44338729 | 19.20 |
Nrcam |
neuronal cell adhesion molecule |
9325 |
0.18 |
chr2_28525282_28526472 | 19.13 |
Ralgds |
ral guanine nucleotide dissociation stimulator |
1973 |
0.2 |
chr10_43023952_43024111 | 19.10 |
Gm47815 |
predicted gene, 47815 |
10962 |
0.22 |
chr14_71963403_71963695 | 19.05 |
4930434J06Rik |
RIKEN cDNA 4930434J06 gene |
50458 |
0.18 |
chr5_14025201_14025420 | 19.05 |
Sema3e |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
34 |
0.97 |
chr19_59541928_59542088 | 18.98 |
Gm18161 |
predicted gene, 18161 |
1557 |
0.42 |
chr19_19246912_19247248 | 18.97 |
Gm25437 |
predicted gene, 25437 |
28819 |
0.17 |
chr18_81830833_81831208 | 18.95 |
Gm30454 |
predicted gene, 30454 |
18996 |
0.19 |
chr4_81536815_81537138 | 18.95 |
Gm11765 |
predicted gene 11765 |
75244 |
0.11 |
chr11_81612012_81612171 | 18.94 |
Gm11418 |
predicted gene 11418 |
24730 |
0.22 |
chr8_94154535_94154978 | 18.92 |
Mt3 |
metallothionein 3 |
2010 |
0.19 |
chr18_8871747_8871953 | 18.90 |
Gm37148 |
predicted gene, 37148 |
56385 |
0.14 |
chr1_193369767_193370837 | 18.90 |
Camk1g |
calcium/calmodulin-dependent protein kinase I gamma |
4 |
0.97 |
chr12_29095750_29095939 | 18.89 |
4833405L11Rik |
RIKEN cDNA 4833405L11 gene |
10893 |
0.23 |
chr17_83889634_83890169 | 18.86 |
1810073O08Rik |
RIKEN cDNA 1810073O08 gene |
28036 |
0.12 |
chr13_57740583_57740756 | 18.86 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
166918 |
0.04 |
chr1_89550370_89550583 | 18.83 |
Gm25180 |
predicted gene, 25180 |
12884 |
0.18 |
chr10_94378473_94378739 | 18.77 |
Gm16155 |
predicted gene 16155 |
30285 |
0.18 |
chr8_12127510_12127825 | 18.74 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
151152 |
0.03 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.7 | 26.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
8.7 | 26.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
8.4 | 25.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
7.7 | 30.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
7.1 | 21.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
6.5 | 32.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
6.3 | 18.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
6.0 | 36.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
5.5 | 16.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
5.5 | 16.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
5.4 | 16.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
5.3 | 21.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
5.3 | 10.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
5.2 | 20.8 | GO:0060594 | mammary gland specification(GO:0060594) |
5.1 | 25.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
5.1 | 15.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
5.1 | 5.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
5.0 | 19.8 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
4.9 | 9.9 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
4.9 | 19.6 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
4.9 | 19.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
4.8 | 14.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
4.6 | 22.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
4.4 | 13.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
4.4 | 17.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
4.3 | 39.1 | GO:0031223 | auditory behavior(GO:0031223) |
4.1 | 12.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
4.0 | 36.2 | GO:0060539 | diaphragm development(GO:0060539) |
4.0 | 15.9 | GO:0007412 | axon target recognition(GO:0007412) |
3.7 | 11.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
3.7 | 14.9 | GO:0060486 | Clara cell differentiation(GO:0060486) |
3.7 | 11.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.7 | 14.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.7 | 11.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
3.6 | 3.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
3.6 | 25.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
3.5 | 10.6 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
3.4 | 10.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
3.4 | 13.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
3.4 | 20.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
3.3 | 6.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
3.3 | 16.6 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
3.3 | 6.6 | GO:0035973 | aggrephagy(GO:0035973) |
3.2 | 12.8 | GO:0008355 | olfactory learning(GO:0008355) |
3.2 | 6.3 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
3.1 | 3.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
3.1 | 15.5 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
3.1 | 9.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
3.1 | 18.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
3.0 | 15.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
3.0 | 9.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
3.0 | 11.9 | GO:0030035 | microspike assembly(GO:0030035) |
3.0 | 3.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.9 | 8.7 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.9 | 8.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.8 | 14.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.8 | 8.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.7 | 13.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
2.7 | 13.3 | GO:0021764 | amygdala development(GO:0021764) |
2.6 | 7.9 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
2.6 | 21.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
2.6 | 5.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.6 | 28.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
2.6 | 23.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
2.6 | 7.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
2.5 | 10.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.5 | 5.1 | GO:0014891 | striated muscle atrophy(GO:0014891) |
2.5 | 7.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
2.5 | 2.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
2.4 | 2.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.4 | 12.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.4 | 9.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.4 | 14.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
2.3 | 7.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.3 | 2.3 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.3 | 2.3 | GO:0014028 | notochord formation(GO:0014028) |
2.3 | 16.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.3 | 13.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
2.3 | 4.5 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
2.3 | 4.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.2 | 4.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.2 | 8.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.2 | 19.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.2 | 6.6 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.2 | 13.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
2.1 | 8.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
2.1 | 6.4 | GO:0061548 | ganglion development(GO:0061548) |
2.1 | 16.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.1 | 10.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.1 | 4.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
2.1 | 14.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
2.1 | 8.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
2.1 | 8.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
2.1 | 4.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
2.1 | 6.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
2.1 | 4.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
2.1 | 16.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
2.1 | 2.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.1 | 16.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
2.0 | 2.0 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
2.0 | 4.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
2.0 | 16.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.0 | 38.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.0 | 10.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.0 | 8.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
2.0 | 2.0 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
2.0 | 21.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
2.0 | 8.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.0 | 6.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
2.0 | 9.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
2.0 | 7.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.0 | 3.9 | GO:0048840 | otolith development(GO:0048840) |
2.0 | 15.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.9 | 27.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
1.9 | 3.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.9 | 3.9 | GO:0030421 | defecation(GO:0030421) |
1.9 | 15.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.9 | 9.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.9 | 5.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.8 | 5.5 | GO:0002339 | B cell selection(GO:0002339) |
1.8 | 7.3 | GO:0030091 | protein repair(GO:0030091) |
1.8 | 3.6 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.8 | 3.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.8 | 5.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.8 | 10.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.8 | 8.8 | GO:0048664 | neuron fate determination(GO:0048664) |
1.8 | 14.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.7 | 3.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.7 | 13.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.7 | 8.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.7 | 5.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.7 | 5.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.7 | 5.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.7 | 6.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.7 | 5.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.7 | 6.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.7 | 5.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
1.7 | 13.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.7 | 3.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.7 | 25.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.7 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.7 | 28.1 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
1.6 | 4.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.6 | 4.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.6 | 31.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.6 | 6.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.6 | 16.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.6 | 22.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.6 | 1.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.6 | 3.2 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
1.6 | 8.1 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.6 | 3.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.6 | 25.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.6 | 4.8 | GO:1903416 | response to glycoside(GO:1903416) |
1.6 | 4.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.6 | 6.4 | GO:0061055 | myotome development(GO:0061055) |
1.6 | 6.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.6 | 9.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.6 | 4.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.6 | 7.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.6 | 4.7 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.6 | 1.6 | GO:0021586 | pons maturation(GO:0021586) |
1.5 | 4.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.5 | 3.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.5 | 15.3 | GO:0001553 | luteinization(GO:0001553) |
1.5 | 3.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.5 | 13.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.5 | 45.5 | GO:0060612 | adipose tissue development(GO:0060612) |
1.5 | 12.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.5 | 16.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.5 | 4.5 | GO:0035826 | rubidium ion transport(GO:0035826) |
1.5 | 4.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.5 | 4.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.5 | 3.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.5 | 11.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
1.5 | 4.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.5 | 4.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.5 | 5.9 | GO:0015808 | L-alanine transport(GO:0015808) |
1.5 | 4.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.5 | 1.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.5 | 8.7 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.5 | 4.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.5 | 2.9 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.5 | 7.3 | GO:0071476 | cellular hypotonic response(GO:0071476) |
1.4 | 7.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.4 | 7.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.4 | 4.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.4 | 5.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.4 | 18.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.4 | 2.8 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 1.4 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.4 | 4.3 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
1.4 | 4.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.4 | 5.6 | GO:0034238 | macrophage fusion(GO:0034238) |
1.4 | 4.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.4 | 15.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.4 | 8.4 | GO:0060004 | reflex(GO:0060004) |
1.4 | 11.1 | GO:0050957 | equilibrioception(GO:0050957) |
1.4 | 5.5 | GO:0015705 | iodide transport(GO:0015705) |
1.4 | 5.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.4 | 2.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.4 | 5.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.4 | 9.6 | GO:0060013 | righting reflex(GO:0060013) |
1.4 | 5.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.4 | 20.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.4 | 1.4 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
1.4 | 9.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.4 | 9.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.4 | 4.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.3 | 1.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.3 | 8.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.3 | 5.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.3 | 1.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.3 | 6.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.3 | 2.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.3 | 25.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.3 | 3.9 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.3 | 1.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.3 | 49.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.3 | 3.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.3 | 3.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.3 | 1.3 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.3 | 3.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.3 | 2.5 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.3 | 6.3 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) positive regulation of brown fat cell differentiation(GO:0090336) |
1.3 | 11.3 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
1.3 | 3.8 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
1.2 | 5.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.2 | 4.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.2 | 1.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
1.2 | 6.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.2 | 4.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.2 | 3.6 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
1.2 | 4.8 | GO:0035627 | ceramide transport(GO:0035627) |
1.2 | 2.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.2 | 3.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
1.2 | 11.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.2 | 1.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
1.2 | 3.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.2 | 2.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.2 | 11.6 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
1.2 | 1.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.1 | 8.0 | GO:0021756 | striatum development(GO:0021756) |
1.1 | 4.5 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
1.1 | 3.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.1 | 2.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.1 | 3.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.1 | 5.5 | GO:0006265 | DNA topological change(GO:0006265) |
1.1 | 1.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
1.1 | 34.3 | GO:0007520 | myoblast fusion(GO:0007520) |
1.1 | 2.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.1 | 3.3 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.1 | 7.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.1 | 3.2 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.1 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
1.1 | 3.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.1 | 2.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.1 | 10.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.1 | 5.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.0 | 3.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.0 | 3.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.0 | 2.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.0 | 3.1 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
1.0 | 1.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.0 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.0 | 5.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.0 | 3.0 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.0 | 4.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
1.0 | 5.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.0 | 3.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.0 | 4.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.0 | 1.0 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 12.9 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.0 | 2.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.0 | 5.9 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.0 | 1.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.0 | 5.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
1.0 | 2.9 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.0 | 2.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.0 | 1.0 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
1.0 | 2.9 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
1.0 | 1.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.0 | 2.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.0 | 1.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.0 | 4.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.0 | 4.8 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
1.0 | 3.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.9 | 22.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.9 | 5.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.9 | 1.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 3.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.9 | 5.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.9 | 0.9 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.9 | 2.8 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.9 | 3.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.9 | 2.8 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 1.8 | GO:0030578 | PML body organization(GO:0030578) |
0.9 | 1.8 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.9 | 3.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.9 | 2.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.9 | 0.9 | GO:0021544 | subpallium development(GO:0021544) |
0.9 | 4.5 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.9 | 0.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.9 | 2.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.9 | 2.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.9 | 4.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.9 | 2.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.9 | 1.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.9 | 2.7 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.9 | 4.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.9 | 7.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.9 | 7.0 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.9 | 4.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.9 | 0.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.9 | 0.9 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.9 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.9 | 3.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.9 | 0.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.9 | 1.7 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.9 | 3.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.9 | 9.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.9 | 4.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.9 | 4.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.8 | 3.4 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.8 | 9.3 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.8 | 1.7 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.8 | 1.7 | GO:0060437 | lung growth(GO:0060437) |
0.8 | 0.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.8 | 1.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.8 | 7.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.8 | 1.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.8 | 5.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.8 | 4.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 8.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.8 | 2.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.8 | 9.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.8 | 1.6 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.8 | 2.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.8 | 6.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.8 | 2.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.8 | 4.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.8 | 1.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.8 | 3.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.8 | 0.8 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.8 | 2.4 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.8 | 0.8 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.8 | 5.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.8 | 1.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.8 | 3.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.8 | 3.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.8 | 11.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.8 | 1.5 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.8 | 2.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.8 | 1.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.8 | 1.5 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.8 | 4.6 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.8 | 5.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.8 | 2.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.8 | 6.8 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.7 | 0.7 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 3.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.7 | 0.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 3.7 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.7 | 6.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.7 | 0.7 | GO:0060433 | bronchus development(GO:0060433) |
0.7 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 5.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.7 | 2.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.7 | 1.5 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.7 | 0.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.7 | 2.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.7 | 0.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.7 | 2.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.7 | 2.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.7 | 9.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.7 | 3.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.7 | 1.4 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.7 | 2.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.7 | 0.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.7 | 1.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.7 | 3.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.7 | 11.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 1.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.7 | 3.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.7 | 2.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.7 | 2.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 3.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.7 | 2.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.7 | 1.4 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.7 | 2.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 3.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.7 | 4.2 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.7 | 0.7 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.7 | 1.4 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.7 | 6.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.7 | 0.7 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.7 | 1.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.7 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 4.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.7 | 4.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.7 | 2.7 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.7 | 2.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.7 | 1.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 0.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.7 | 1.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.7 | 1.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.7 | 2.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.7 | 2.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.7 | 1.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.7 | 2.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.7 | 7.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.7 | 3.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.7 | 0.7 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.7 | 0.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.6 | 1.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 3.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.6 | 5.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 1.3 | GO:0098901 | regulation of cardiac muscle cell action potential(GO:0098901) |
0.6 | 1.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.6 | 1.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.6 | 3.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.6 | 5.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.6 | 1.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 3.2 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.6 | 12.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.6 | 2.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.6 | 3.8 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.6 | 2.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.6 | 1.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.6 | 0.6 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.6 | 5.0 | GO:0034776 | response to histamine(GO:0034776) |
0.6 | 3.1 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.6 | 7.4 | GO:0042407 | cristae formation(GO:0042407) |
0.6 | 10.4 | GO:0035640 | exploration behavior(GO:0035640) |
0.6 | 1.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.6 | 1.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.6 | 4.3 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.6 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.6 | 1.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.6 | 0.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 0.6 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.6 | 3.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 1.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.6 | 0.6 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.6 | 1.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 1.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.6 | 1.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 5.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.6 | 1.2 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.6 | 0.6 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.6 | 1.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.6 | 0.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.6 | 1.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 4.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.6 | 2.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 0.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.6 | 3.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.6 | 1.7 | GO:0050955 | thermoception(GO:0050955) |
0.6 | 1.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 1.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.6 | 0.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.6 | 1.7 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.6 | 1.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.6 | 4.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.6 | 1.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.6 | 1.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.6 | 4.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.6 | 2.3 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.6 | 0.6 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.6 | 4.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.6 | 0.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.6 | 1.7 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.6 | 1.7 | GO:0033504 | floor plate development(GO:0033504) |
0.5 | 1.6 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.5 | 7.6 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.5 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 5.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.5 | 1.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.5 | 1.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.5 | 1.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.5 | 2.1 | GO:0032196 | transposition(GO:0032196) |
0.5 | 0.5 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.5 | 1.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.5 | 6.8 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.5 | 1.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.5 | 3.7 | GO:0098751 | bone cell development(GO:0098751) |
0.5 | 0.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.5 | 2.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.5 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.5 | 1.6 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 1.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 3.6 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.5 | 1.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.5 | 1.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 1.0 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.5 | 5.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.5 | 1.0 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.5 | 1.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.5 | 2.0 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 1.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 1.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 2.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.5 | 1.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 0.5 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.5 | 9.6 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.5 | 1.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 0.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 1.5 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 | 2.0 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.5 | 1.0 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
0.5 | 0.5 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.5 | 3.5 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.5 | 1.5 | GO:0003157 | endocardium development(GO:0003157) |
0.5 | 2.0 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.5 | 3.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.5 | 51.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.5 | 2.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.5 | 4.9 | GO:0001967 | suckling behavior(GO:0001967) |
0.5 | 1.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.5 | 0.5 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.5 | 0.5 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.5 | 7.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 1.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 0.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.5 | 2.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 1.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 1.5 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.5 | 1.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 1.0 | GO:0046959 | habituation(GO:0046959) |
0.5 | 3.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 4.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.5 | 1.4 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.5 | 1.4 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.5 | 0.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 0.5 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.5 | 1.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 0.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.5 | 1.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.5 | 0.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.5 | 1.9 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.5 | 8.5 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.5 | 2.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 1.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.5 | 0.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.5 | 1.9 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.5 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 0.5 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.5 | 5.1 | GO:0030901 | midbrain development(GO:0030901) |
0.5 | 0.9 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 1.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 5.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.5 | 0.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.5 | 2.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.5 | 2.7 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.5 | 0.9 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 3.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 0.4 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.4 | 5.8 | GO:0001881 | receptor recycling(GO:0001881) |
0.4 | 20.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 1.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 0.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 2.6 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.4 | 26.4 | GO:0007411 | axon guidance(GO:0007411) |
0.4 | 1.8 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.4 | 0.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 1.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 2.2 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.4 | 11.8 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.4 | 1.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 1.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.4 | 7.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.4 | 2.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 0.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 1.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 2.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.4 | 22.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.4 | 0.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 2.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.4 | 1.7 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.4 | 1.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 2.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 1.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 1.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.4 | 1.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.4 | 1.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 1.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 0.4 | GO:0097369 | sodium ion import(GO:0097369) |
0.4 | 0.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 1.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 2.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 1.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.4 | 2.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 2.0 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 6.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.4 | 0.8 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.4 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 1.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 1.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 1.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 1.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.4 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.4 | 0.8 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 1.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.4 | 0.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.4 | 2.8 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.4 | 2.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 1.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.4 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 0.4 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.4 | 1.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.4 | 0.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.4 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 2.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 0.8 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 3.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 0.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.4 | 0.4 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.4 | 2.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 3.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.4 | 0.7 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 0.4 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 10.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.4 | 1.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.4 | 1.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 0.7 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.4 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 0.4 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 1.5 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 0.7 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.4 | 0.4 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.4 | 1.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 1.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 1.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 1.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 0.7 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.4 | 2.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 1.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 5.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.4 | 2.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 1.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 1.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.3 | 0.3 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.7 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.3 | 1.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 1.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 0.7 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 2.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 1.0 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 1.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 6.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 1.3 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.3 | 0.7 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 | 1.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 1.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 5.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 4.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.7 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.3 | 1.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 1.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 1.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 1.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.3 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 1.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 3.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 1.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 1.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 11.9 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.3 | 4.1 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.3 | 0.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 3.1 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.3 | 16.8 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.3 | 0.6 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.3 | 1.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 0.3 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.3 | 0.6 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 1.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 0.3 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.3 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 0.6 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.3 | 2.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.3 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 1.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 5.6 | GO:0008542 | visual learning(GO:0008542) |
0.3 | 0.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.3 | 0.6 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 1.2 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.3 | 4.0 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.3 | 0.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 0.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 2.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 11.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.6 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 0.6 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.3 | 1.7 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.3 | 2.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 0.6 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.6 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) positive regulation of phospholipase A2 activity(GO:0032430) |
0.3 | 1.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 2.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 0.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 1.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 0.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 0.3 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.3 | 0.8 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 4.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 0.8 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.8 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 0.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 0.8 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 1.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.3 | 1.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 1.3 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.3 | 1.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.3 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.3 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.3 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.5 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.3 | 1.5 | GO:0001964 | startle response(GO:0001964) |
0.3 | 0.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 4.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 1.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.2 | 0.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 2.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 2.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.7 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.2 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 1.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 1.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 2.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.7 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.2 | 0.7 | GO:0045006 | DNA deamination(GO:0045006) |
0.2 | 1.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 25.0 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.2 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.2 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.2 | 1.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 2.8 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 1.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.7 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.9 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 1.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 0.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.4 | GO:0033363 | secretory granule organization(GO:0033363) |
0.2 | 0.8 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.2 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.6 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.2 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 0.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 1.0 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.2 | 0.4 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.2 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 1.0 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.2 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.2 | 0.8 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.2 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.6 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.2 | 2.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 5.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.4 | GO:0070268 | cornification(GO:0070268) |
0.2 | 1.4 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.6 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 1.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 1.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.4 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 0.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.5 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 0.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 2.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 0.2 | GO:0060459 | left lung development(GO:0060459) |
0.2 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.2 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 3.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.2 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 1.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 1.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.2 | 0.2 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 2.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.2 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.2 | 2.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 31.4 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.2 | 2.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 2.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 1.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 1.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.7 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 0.4 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 1.0 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 3.5 | GO:0098773 | skin epidermis development(GO:0098773) |
0.1 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.1 | 0.1 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 1.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.3 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.3 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.1 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.3 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 1.2 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.1 | GO:0003174 | mitral valve development(GO:0003174) mitral valve morphogenesis(GO:0003183) |
0.1 | 6.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.5 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.4 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.4 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 4.6 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.3 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 1.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.1 | GO:0014062 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.1 | 1.6 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.2 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.2 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.3 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.1 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.9 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.1 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 1.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 2.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.3 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.7 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 4.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.3 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.9 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 1.3 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.5 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.1 | 0.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 1.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.4 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.9 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 1.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 1.0 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.2 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 1.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.3 | GO:0001756 | somitogenesis(GO:0001756) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.0 | 0.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.0 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 18.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 18.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
5.6 | 11.2 | GO:0097427 | microtubule bundle(GO:0097427) |
5.4 | 16.1 | GO:0070552 | BRISC complex(GO:0070552) |
5.2 | 15.6 | GO:1990635 | proximal dendrite(GO:1990635) |
5.2 | 20.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
5.1 | 15.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
5.0 | 5.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
5.0 | 30.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
4.5 | 22.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.8 | 11.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
3.5 | 10.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.3 | 23.4 | GO:0045180 | basal cortex(GO:0045180) |
2.9 | 20.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.8 | 19.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.8 | 11.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
2.7 | 5.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.6 | 10.4 | GO:1990357 | terminal web(GO:1990357) |
2.5 | 7.6 | GO:0097441 | basilar dendrite(GO:0097441) |
2.5 | 17.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.4 | 14.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.4 | 7.1 | GO:0072534 | perineuronal net(GO:0072534) |
2.3 | 6.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.2 | 6.6 | GO:1990393 | 3M complex(GO:1990393) |
2.1 | 2.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.0 | 13.8 | GO:0032584 | growth cone membrane(GO:0032584) |
1.8 | 5.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.8 | 31.3 | GO:0043034 | costamere(GO:0043034) |
1.8 | 19.9 | GO:0043194 | axon initial segment(GO:0043194) |
1.7 | 49.2 | GO:0031941 | filamentous actin(GO:0031941) |
1.7 | 8.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.7 | 6.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.6 | 17.9 | GO:0042555 | MCM complex(GO:0042555) |
1.6 | 1.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.6 | 7.9 | GO:0000235 | astral microtubule(GO:0000235) |
1.6 | 30.0 | GO:0030673 | axolemma(GO:0030673) |
1.6 | 14.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.6 | 6.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.6 | 4.7 | GO:0032280 | symmetric synapse(GO:0032280) |
1.6 | 4.7 | GO:0032010 | phagolysosome(GO:0032010) |
1.5 | 24.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.5 | 90.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.4 | 5.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.4 | 4.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.4 | 4.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.4 | 4.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.4 | 5.4 | GO:0030891 | VCB complex(GO:0030891) |
1.3 | 30.9 | GO:0044295 | axonal growth cone(GO:0044295) |
1.3 | 9.4 | GO:0033263 | CORVET complex(GO:0033263) |
1.3 | 3.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.3 | 14.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.3 | 15.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.3 | 2.5 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.3 | 10.1 | GO:0043083 | synaptic cleft(GO:0043083) |
1.2 | 1.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.2 | 12.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.2 | 3.5 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.1 | 9.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.1 | 19.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.1 | 30.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.1 | 26.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 3.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.1 | 39.0 | GO:0043198 | dendritic shaft(GO:0043198) |
1.0 | 21.9 | GO:0005605 | basal lamina(GO:0005605) |
1.0 | 4.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.0 | 10.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.0 | 2.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.0 | 2.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.0 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 7.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.9 | 14.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.9 | 10.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.9 | 0.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.9 | 4.5 | GO:0005638 | lamin filament(GO:0005638) |
0.9 | 4.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.9 | 2.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.9 | 1.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.9 | 2.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 5.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.8 | 7.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.8 | 1.7 | GO:0044393 | microspike(GO:0044393) |
0.8 | 11.3 | GO:0043205 | fibril(GO:0043205) |
0.8 | 4.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.8 | 3.2 | GO:0000938 | GARP complex(GO:0000938) |
0.8 | 6.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.8 | 3.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 3.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.8 | 2.3 | GO:0036396 | MIS complex(GO:0036396) |
0.8 | 3.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.8 | 12.4 | GO:0097546 | ciliary base(GO:0097546) |
0.8 | 5.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.8 | 4.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 5.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.7 | 6.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.7 | 2.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.7 | 2.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.7 | 7.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.7 | 9.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.7 | 2.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 7.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.7 | 2.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.7 | 4.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 9.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.7 | 6.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 4.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.7 | 2.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.7 | 19.0 | GO:0005921 | gap junction(GO:0005921) |
0.7 | 2.6 | GO:0035363 | histone locus body(GO:0035363) |
0.7 | 3.9 | GO:0032009 | early phagosome(GO:0032009) |
0.7 | 4.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.6 | 4.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.6 | 1.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.6 | 17.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.6 | 1.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 5.0 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.6 | 1.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 8.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 2.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.6 | 3.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 7.8 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.6 | 1.2 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 1.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 1.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 1.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.6 | 10.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 3.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.5 | 1.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.5 | 5.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 7.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.5 | 14.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.5 | 13.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 3.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.5 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 12.1 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 1.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 1.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.5 | 7.2 | GO:0046930 | pore complex(GO:0046930) |
0.5 | 5.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 1.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.5 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 12.8 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 8.5 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 3.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 3.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 1.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.4 | 1.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 0.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.4 | 1.7 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.4 | 55.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 1.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 8.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 1.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 2.4 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 1.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 7.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.4 | 2.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 1.1 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 22.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.4 | 1.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 1.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.4 | 30.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.4 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 7.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 2.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 2.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 2.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 2.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 2.7 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.0 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 13.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 1.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 4.4 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.3 | 1.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.9 | GO:0097433 | dense body(GO:0097433) |
0.3 | 12.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 4.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 6.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 3.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 20.7 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 0.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 0.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 2.1 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 1.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 1.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 5.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 2.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 3.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 5.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.4 | GO:0002177 | manchette(GO:0002177) |
0.3 | 2.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 1.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 3.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 3.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 2.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 10.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 1.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 16.1 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 2.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 73.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 6.0 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.9 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 27.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 2.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 2.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 4.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 37.3 | GO:0045202 | synapse(GO:0045202) |
0.2 | 0.4 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 1.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 0.7 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 16.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 1.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 3.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 1.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 4.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.6 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 3.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 11.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 3.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 1.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 2.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 4.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 2.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 4.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 4.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 6.7 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 3.6 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 2.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 1.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 4.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 4.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 1.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 11.0 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 25.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
8.3 | 33.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
7.8 | 23.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
6.7 | 20.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
6.5 | 19.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
6.3 | 18.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.2 | 31.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
5.6 | 16.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
5.2 | 25.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
5.1 | 5.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
4.9 | 34.5 | GO:0003680 | AT DNA binding(GO:0003680) |
4.9 | 19.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
3.8 | 11.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
3.7 | 29.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
3.5 | 7.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.5 | 10.5 | GO:0043398 | HLH domain binding(GO:0043398) |
3.4 | 17.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
3.1 | 3.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
3.0 | 12.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
3.0 | 8.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.9 | 11.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
2.9 | 17.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
2.8 | 14.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
2.8 | 8.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
2.8 | 11.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
2.7 | 8.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
2.7 | 8.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
2.6 | 23.7 | GO:0038191 | neuropilin binding(GO:0038191) |
2.6 | 44.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
2.6 | 7.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.5 | 12.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.5 | 12.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
2.5 | 17.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.4 | 14.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
2.4 | 48.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.4 | 2.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
2.3 | 7.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.3 | 30.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
2.3 | 18.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
2.3 | 7.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
2.3 | 11.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.2 | 6.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.2 | 17.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
2.2 | 17.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.2 | 6.5 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
2.2 | 4.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
2.2 | 2.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
2.1 | 6.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.1 | 14.7 | GO:0043495 | protein anchor(GO:0043495) |
2.1 | 14.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.1 | 12.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.1 | 10.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.1 | 6.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.0 | 16.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
2.0 | 40.4 | GO:0003785 | actin monomer binding(GO:0003785) |
2.0 | 8.0 | GO:0097001 | ceramide binding(GO:0097001) |
2.0 | 6.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.0 | 7.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.0 | 5.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.9 | 7.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.9 | 9.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.9 | 9.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.8 | 7.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.8 | 12.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.8 | 5.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.8 | 7.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.8 | 5.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.7 | 5.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.7 | 5.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.7 | 5.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.7 | 3.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.7 | 34.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.6 | 4.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.6 | 4.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.6 | 8.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.6 | 14.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.6 | 3.2 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.6 | 25.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.6 | 3.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.6 | 6.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.6 | 4.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.6 | 17.1 | GO:0035198 | miRNA binding(GO:0035198) |
1.5 | 7.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.5 | 4.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.5 | 4.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.5 | 4.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.5 | 22.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
1.4 | 5.6 | GO:0071253 | connexin binding(GO:0071253) |
1.4 | 37.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.4 | 5.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.4 | 12.3 | GO:0039706 | co-receptor binding(GO:0039706) |
1.4 | 1.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.4 | 4.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.3 | 2.7 | GO:0010851 | cyclase regulator activity(GO:0010851) |
1.3 | 1.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.3 | 5.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.3 | 10.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.3 | 6.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.3 | 19.3 | GO:0030553 | cGMP binding(GO:0030553) |
1.3 | 5.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.3 | 8.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.2 | 16.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.2 | 3.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.2 | 6.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.2 | 6.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.2 | 6.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.2 | 1.2 | GO:0005272 | sodium channel activity(GO:0005272) |
1.2 | 4.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.2 | 7.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.1 | 3.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.1 | 1.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.1 | 4.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.1 | 3.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.1 | 13.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.1 | 3.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.1 | 3.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.1 | 6.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.1 | 5.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.1 | 6.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.1 | 5.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 18.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.0 | 6.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.0 | 5.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.0 | 2.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 4.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 14.8 | GO:0015026 | coreceptor activity(GO:0015026) |
1.0 | 10.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.0 | 7.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.0 | 4.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.0 | 9.5 | GO:0005522 | profilin binding(GO:0005522) |
0.9 | 1.9 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.9 | 5.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.9 | 2.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.9 | 2.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 7.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.9 | 2.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.9 | 0.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.9 | 2.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.9 | 2.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.9 | 11.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.9 | 5.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.9 | 2.6 | GO:2001070 | starch binding(GO:2001070) |
0.9 | 2.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.9 | 3.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.9 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.9 | 27.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.9 | 4.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.9 | 11.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.9 | 75.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.8 | 16.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 2.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.8 | 12.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.8 | 8.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.8 | 3.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.8 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.8 | 9.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.8 | 1.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.8 | 4.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 3.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.8 | 15.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.8 | 2.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.8 | 3.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.8 | 1.6 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 2.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 5.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.7 | 6.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.7 | 14.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.7 | 2.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 3.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 3.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 3.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 0.7 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.7 | 1.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 3.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.7 | 8.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.7 | 3.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.7 | 3.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.7 | 2.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.7 | 2.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.7 | 8.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.7 | 14.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 2.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.7 | 2.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 2.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 3.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 5.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.7 | 7.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.7 | 4.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 2.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.7 | 7.9 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.7 | 2.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 3.3 | GO:0048185 | activin binding(GO:0048185) |
0.6 | 2.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.6 | 1.9 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.6 | 3.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 19.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.6 | 7.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 7.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.6 | 1.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 1.8 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.6 | 1.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.6 | 1.8 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.6 | 3.0 | GO:0043426 | MRF binding(GO:0043426) |
0.6 | 1.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 14.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 1.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 7.7 | GO:0070888 | E-box binding(GO:0070888) |
0.6 | 9.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 1.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 1.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.6 | 5.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 4.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.6 | 1.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 5.2 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 3.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 4.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 3.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 2.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 24.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.6 | 1.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 1.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.5 | 1.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 4.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 2.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 5.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.5 | 1.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.5 | 2.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 2.7 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.5 | 2.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 33.5 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.5 | 0.5 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.5 | 3.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.5 | 2.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.5 | 1.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.5 | 4.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.5 | 1.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 1.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 5.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 9.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 2.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.5 | 4.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 3.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 4.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 146.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.5 | 3.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 0.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.5 | 22.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.5 | 0.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 13.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.5 | 7.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 2.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.5 | 2.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 2.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 2.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.5 | 1.4 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.5 | 1.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 26.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.4 | 2.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.4 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 4.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.4 | 0.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.4 | 8.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.4 | 8.8 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.4 | 5.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 2.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 11.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 1.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 5.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 1.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 2.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.4 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 1.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 4.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 2.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 10.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 2.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.9 | GO:0034845 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.4 | 6.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 4.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 0.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 1.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 5.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.4 | 0.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 1.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 13.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 1.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.4 | 0.4 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.4 | 1.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 1.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 2.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.4 | 2.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.0 | GO:0005165 | neurotrophin receptor binding(GO:0005165) neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 2.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 5.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 2.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 6.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.3 | 1.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 1.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 3.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 1.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 1.6 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.3 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 1.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 4.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 29.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 0.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 0.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 4.9 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.3 | 4.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 3.6 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 2.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 6.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 2.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 5.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 2.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 1.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 6.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 1.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 5.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 2.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 3.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.3 | 60.6 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.3 | 2.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 0.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 14.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.3 | 0.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 13.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 6.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.8 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.7 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 2.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 2.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 18.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 2.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 10.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 0.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 4.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 0.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.6 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 2.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.8 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 3.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 2.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 0.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.2 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.2 | 2.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 4.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 3.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.2 | GO:0070697 | activin receptor binding(GO:0070697) |
0.2 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 4.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 4.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 1.4 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 1.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 3.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 3.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 5.0 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.2 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 2.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 11.3 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 1.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 3.7 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 11.9 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 12.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 4.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 45.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.2 | GO:0030550 | acetylcholine receptor regulator activity(GO:0030548) acetylcholine receptor inhibitor activity(GO:0030550) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 1.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 3.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 3.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 2.7 | GO:0005244 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 14.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 6.1 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 1.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.6 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 6.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.2 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.7 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 21.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 38.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.0 | 29.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.8 | 26.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.6 | 22.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.5 | 13.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.4 | 42.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.4 | 15.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.2 | 31.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.1 | 10.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.1 | 19.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.1 | 8.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.0 | 24.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.9 | 12.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.9 | 14.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.9 | 5.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.9 | 13.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.9 | 13.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.8 | 14.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 21.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.8 | 38.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.8 | 29.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.8 | 30.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.7 | 5.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 20.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.7 | 7.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 20.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 15.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.6 | 1.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 19.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 15.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 3.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 17.4 | PID BMP PATHWAY | BMP receptor signaling |
0.5 | 2.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 5.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 9.9 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 5.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 6.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 4.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 3.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 2.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 5.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.4 | 1.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 13.2 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 4.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 3.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 2.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 1.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 74.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 1.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 8.5 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 9.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 4.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 5.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 4.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 7.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 2.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 27.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 6.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 2.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 2.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 2.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 1.5 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 3.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 1.8 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 6.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 2.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 48.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
4.1 | 4.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
3.4 | 36.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.8 | 5.5 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
2.7 | 40.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.6 | 28.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.3 | 29.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
2.2 | 30.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.2 | 4.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
2.0 | 22.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.9 | 25.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.7 | 15.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.5 | 13.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.4 | 55.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.4 | 47.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.4 | 15.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.4 | 32.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.3 | 12.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
1.2 | 52.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.2 | 19.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
1.2 | 1.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.1 | 3.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.1 | 14.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.1 | 2.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
1.1 | 10.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.1 | 4.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.0 | 14.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.0 | 10.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.0 | 6.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.0 | 5.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.9 | 0.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.9 | 0.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.9 | 0.9 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.9 | 5.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 21.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.8 | 3.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.8 | 9.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.8 | 10.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.8 | 11.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 5.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.7 | 10.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 3.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 2.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.7 | 5.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.7 | 3.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 0.7 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.7 | 4.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.7 | 4.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.7 | 8.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.7 | 2.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.7 | 3.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.7 | 8.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 2.6 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.7 | 5.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 12.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 3.2 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.6 | 10.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 5.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 4.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.6 | 1.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.5 | 1.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.5 | 1.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 5.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.5 | 8.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 30.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.5 | 2.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 8.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 6.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.4 | 4.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 5.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 8.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 4.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 7.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 7.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 4.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 2.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 5.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 0.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.3 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 4.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 2.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 2.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 11.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 6.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 0.8 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 7.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 0.2 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 3.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 2.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 1.8 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.2 | 2.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 4.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 3.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 2.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 7.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 1.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 5.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 25.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 1.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 4.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 3.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 5.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 0.2 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 0.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 3.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |